(TW) Tradeweb Markets - Overview
Stock: Electronic Marketplaces, Rates, Credit, Money Markets, Equities
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.38% |
| Yield on Cost 5y | 0.95% |
| Yield CAGR 5y | 10.67% |
| Payout Consistency | 98.8% |
| Payout Ratio | 14.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 33.2% |
| Relative Tail Risk | -5.58% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.21 |
| Alpha | -14.91 |
| Character TTM | |
|---|---|
| Beta | 0.417 |
| Beta Downside | 0.702 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.05% |
| CAGR/Max DD | 0.51 |
Description: TW Tradeweb Markets December 17, 2025
Tradeweb Markets Inc. (NASDAQ:TW) operates global electronic marketplaces that enable institutional participants to trade across rates, credit, money-markets, and equity products. Its suite includes pre-trade analytics, execution and processing services, and post-trade reporting, delivered via flexible order-routing tools for asset managers, hedge funds, banks, dealers, and advisory firms.
Key performance indicators from the most recent fiscal year show revenue of roughly $1.4 billion, up about 13 % year-over-year, and net income of $250 million, reflecting strong scaling of its fixed-income electronic trading volumes, which now exceed $1.2 trillion daily. The platform’s market-share in U.S. Treasury electronic trading is estimated at ~30 %, and its Dealerweb and Tradeweb Direct solutions support both pure electronic and hybrid voice-plus-electronic workflows.
Demand for Tradeweb’s services is driven by higher interest-rate volatility, which raises the value of real-time pricing and liquidity-aggregation tools, and by a broader industry shift toward digital, transparent trading venues mandated by post-2008 regulatory reforms. For a deeper dive into Tradeweb’s valuation metrics and scenario analysis, you might explore the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 812.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 2.42 > 1.0 |
| NWC/Revenue: 105.9% < 20% (prev 73.49%; Δ 32.45% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.17b > Net Income 812.8m |
| Net Debt (-1.95b) to EBITDA (1.43b): -1.36 < 3 |
| Current Ratio: 13.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (214.7m) vs 12m ago -0.09% < -2% |
| Gross Margin: 66.05% > 18% (prev 0.66%; Δ 6539 % > 0.5%) |
| Asset Turnover: 26.56% > 50% (prev 23.75%; Δ 2.81% > 0%) |
| Interest Coverage Ratio: 606.3 > 6 (EBITDA TTM 1.43b / Interest Expense TTM 1.94m) |
Altman Z'' 5.09
| A: 0.27 (Total Current Assets 2.34b - Total Current Liabilities 168.2m) / Total Assets 8.19b |
| B: 0.20 (Retained Earnings 1.60b / Total Assets 8.19b) |
| C: 0.15 (EBIT TTM 1.18b / Avg Total Assets 7.73b) |
| D: 1.61 (Book Value of Equity 1.61b / Total Liabilities 1.00b) |
| Altman-Z'' Score: 5.09 = AAA |
Beneish M -3.20
| DSRI: 0.75 (Receivables 257.8m/290.1m, Revenue 2.05b/1.73b) |
| GMI: 0.99 (GM 66.05% / 65.66%) |
| AQI: 0.91 (AQ_t 0.69 / AQ_t-1 0.76) |
| SGI: 1.19 (Revenue 2.05b / 1.73b) |
| TATA: -0.04 (NI 812.8m - CFO 1.17b) / TA 8.19b) |
| Beneish M-Score: -3.20 (Cap -4..+1) = AA |
What is the price of TW shares?
Over the past week, the price has changed by +12.48%, over one month by +11.36%, over three months by +5.73% and over the past year by -7.17%.
Is TW a buy, sell or hold?
- StrongBuy: 6
- Buy: 5
- Hold: 4
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the TW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 127.7 | 10.4% |
| Analysts Target Price | 127.7 | 10.4% |
| ValueRay Target Price | 121.3 | 4.8% |
TW Fundamental Data Overview February 09, 2026
P/E Forward = 31.9489
P/S = 11.9474
P/B = 3.663
P/EG = 2.5617
Revenue TTM = 2.05b USD
EBIT TTM = 1.18b USD
EBITDA TTM = 1.43b USD
Long Term Debt = 139.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 139.2m USD (from shortTermDebt, last fiscal year)
Debt = 139.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.95b USD (from netDebt column, last quarter)
Enterprise Value = 22.55b USD (24.50b + Debt 139.2m - CCE 2.09b)
Interest Coverage Ratio = 606.3 (Ebit TTM 1.18b / Interest Expense TTM 1.94m)
EV/FCF = 20.32x (Enterprise Value 22.55b / FCF TTM 1.11b)
FCF Yield = 4.92% (FCF TTM 1.11b / Enterprise Value 22.55b)
FCF Margin = 54.07% (FCF TTM 1.11b / Revenue TTM 2.05b)
Net Margin = 39.60% (Net Income TTM 812.8m / Revenue TTM 2.05b)
Gross Margin = 66.05% ((Revenue TTM 2.05b - Cost of Revenue TTM 696.8m) / Revenue TTM)
Gross Margin QoQ = 64.46% (prev 67.56%)
Tobins Q-Ratio = 2.75 (Enterprise Value 22.55b / Total Assets 8.19b)
Interest Expense / Debt = 0.29% (Interest Expense 403.0k / Debt 139.2m)
Taxrate = 19.62% (89.6m / 456.7m)
NOPAT = 946.1m (EBIT 1.18b * (1 - 19.62%))
Current Ratio = 13.93 (Total Current Assets 2.34b / Total Current Liabilities 168.2m)
Debt / Equity = 0.02 (Debt 139.2m / totalStockholderEquity, last quarter 6.51b)
Debt / EBITDA = -1.36 (Net Debt -1.95b / EBITDA 1.43b)
Debt / FCF = -1.75 (Net Debt -1.95b / FCF TTM 1.11b)
Total Stockholder Equity = 6.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.52% (Net Income 812.8m / Total Assets 8.19b)
RoE = 13.10% (Net Income TTM 812.8m / Total Stockholder Equity 6.21b)
RoCE = 18.55% (EBIT 1.18b / Capital Employed (Equity 6.21b + L.T.Debt 139.2m))
RoIC = 15.24% (NOPAT 946.1m / Invested Capital 6.21b)
WACC = 7.41% (E(24.50b)/V(24.64b) * Re(7.45%) + D(139.2m)/V(24.64b) * Rd(0.29%) * (1-Tc(0.20)))
Discount Rate = 7.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.21%
[DCF Debug] Terminal Value 82.82% ; FCFF base≈989.4m ; Y1≈1.18b ; Y5≈1.88b
Fair Price DCF = 329.4 (EV 36.15b - Net Debt -1.95b = Equity 38.10b / Shares 115.7m; r=7.41% [WACC]; 5y FCF grow 20.90% → 2.90% )
EPS Correlation: 97.37 | EPS CAGR: 17.19% | SUE: 3.74 | # QB: 1
Revenue Correlation: 96.23 | Revenue CAGR: 14.71% | SUE: -0.86 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.98 | Chg30d=+0.034 | Revisions Net=-2 | Analysts=11
EPS current Year (2026-12-31): EPS=3.94 | Chg30d=+0.112 | Revisions Net=+2 | Growth EPS=+13.4% | Growth Revenue=+12.0%
EPS next Year (2027-12-31): EPS=4.36 | Chg30d=+0.113 | Revisions Net=+2 | Growth EPS=+10.7% | Growth Revenue=+10.1%